Concepedia

Lawrence R. McGee

LR

Statistics

Publications

36

Citations

2.4K

H-Index

27

Active since

1976

Affiliations

Amgen (United States)(Current)

DuPont (United States)

Experimental Station

Gilead Sciences (United States)

California Institute of Technology

Lawrence R. McGee is an author at Amgen (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1976–2018

36

Publications

36

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 296 citations · Full text

, , +7

Chiral enolate design

David A. Evans, James M. Takacs, Lawrence R. McGee et al. · Pure and Applied Chemistry · 1981 · 276 citations · Full text

, , +3

Practical Total Synthesis of the Anti-Influenza Drug GS-4104

John C. Rohloff, Kenneth M. Kent, Michael J. Postich et al. · The Journal of Organic Chemistry · 1998 · 195 citations

, , +11

Aldol diastereoselection zirconium enolates. Product-selective, enolate structure independent condensations.

David A. Evans, Lawrence R. McGee · Tetrahedron Letters · 1980 · 150 citations

, , +8

Enantioselective aldol condensations. 3. Erythro-selective condensations via zirconium enolates

David A. Evans, Lawrence R. McGee · Journal of the American Chemical Society · 1981 · 126 citations

, , +6

1–5 of 36